U.S. Real Estate Stock News

With AEVEX trading at US$24.87, you might be wondering whether the current price really lines up with what the stock could be worth based on fundamentals. Over the short term, the share price has been under some pressure, with the stock down 0.8% over the last week and down 7.6% year to date. This may be changing how the market views its risk and reward profile. Recent coverage of AEVEX has focused less on short term headlines and more on giving investors a consistent view of the company...

CareDx (NasdaqGM:CDNA) disclosed that a long standing qui tam lawsuit has been dismissed. The company had previously announced that the Department of Justice closed a related investigation without findings of wrongdoing. Together, these outcomes remove a material legal overhang tied to historical compliance questions. CareDx focuses on transplant diagnostics and related services, an area where regulatory oversight and reimbursement policies are central to the business model. For investors...

Considering whether National Storage Affiliates Trust at around US$41.02 is offering fair value right now or if the price is out of line with the fundamentals. The stock is up 47.1% year to date and 20.2% over the past year, even though it has fallen 6.1% in the last week and 2.1% over the past month. Recent market attention has focused on how self storage REITs are positioned within real estate, as investors reassess income focused sectors and their sensitivity to interest rates. This...

Charles River Laboratories International (NYSE:CRL) has entered into a partnership with MEDIPOST to support development and commercialization of cell therapies across Asia-Pacific and North America. The company is supplying biologics and GMP testing services to MEDIPOST’s global pipeline of regenerative medicine products. At the same time, Charles River introduced major upgrades to its digital pathology platform, adding AI-powered and fully digital workflows. The new digital pathology...

Payments platform DLocal (NasdaqGS:DLO) has reported Q1 2026 revenue of US$335.9 million and basic EPS of US$0.14, with trailing twelve month revenue at about US$1.2 billion and EPS of US$0.66 framing the broader earnings picture. Over the past year, the company has seen revenue lift from US$745.97 million to US$1.21 billion and EPS move from US$0.42 to US$0.66 on a trailing basis, alongside earnings growth of 28.7% and a trailing net margin of 15.8% versus 19.2% in the prior year. The latest...

Paysign (PAYS) is back in focus after reporting record first quarter 2026 results, with revenue of US$28.04 million and net income of US$5.44 million, while its patient affordability business became the largest contributor. See our latest analysis for Paysign. The share price has been volatile around these earnings, slipping 2.94% on the day and 9.65% over the past week. However, the 90 day share price return of 65.78% and 1 year total shareholder return of 55.89% still point to strong recent...

Sociedad Química y Minera de Chile (NYSE:SQM) has proposed raising its final dividend payout ratio from 30% to 50% of net income. The company has also finalized a lithium joint venture with Chilean state miner Codelco, focused on lithium operations. Sociedad Química y Minera de Chile, or SQM, is a Chile based chemicals and mining company with a major focus on lithium for battery production, along with other specialty fertilizers and industrial chemicals. The combination of a higher proposed...

Credicorp (NYSE:BAP) has just posted another set of quarterly numbers that keep the focus on earnings power, with Q4 2025 revenue at S/5.4 billion and basic EPS of S/19.9 alongside net income of S/1.6 billion. Over the past few quarters, revenue has moved from S/4.6 billion in Q3 2024 to S/5.1 billion in Q4 2024 and then to S/5.4 billion in Q4 2025. Quarterly EPS shifted from S/14.0 to S/22.4 at the start of 2025 before landing at S/19.9 in the latest period, highlighting trailing earnings...

Pinnacle Financial Partners (NYSE:PNFP) has completed its merger with Synovus Financial Corp., creating a regional bank with over US$120b in assets. The combined bank now operates on a new shared platform serving customers across the southeastern U.S. Following the merger, Douglas Hromco has been appointed chief security officer to oversee cybersecurity, fraud prevention, and physical security for the enlarged organization. For you as an investor, this deal moves NYSE:PNFP further into the...

ARS Pharmaceuticals (SPRY) opened Q1 2026 with trailing 12 month revenue of about US$84.3 million and a reported loss of roughly US$171.3 million, translating to basic EPS of about US$1.74 loss, while the stock trades around US$7.43. Over recent quarters, the company has seen revenue move from US$7.97 million in Q1 2025 to US$28.09 million in Q4 2025, with basic EPS shifting from a loss of US$0.35 in Q1 2025 to a loss of US$0.42 in Q4 2025. This sets up a story where rising revenue is still...

ReposiTrak (TRAK) has reported Q3 2026 revenue of about US$5.9 million with basic EPS of roughly US$0.11, against a trailing 12 month EPS figure of about US$0.39 that reflects earnings growth of 11.5% over the past year and 17% per year over five years. Over recent quarters, the company has seen revenue move around the US$5.5 million to US$6.0 million range while quarterly EPS has tracked between roughly US$0.08 and US$0.11, supported by trailing 12 month net income of about US$7.1 million...

WEX (NYSE:WEX) has authorized a new $1b share repurchase program. The company has appointed David Foss as independent Chair, separating the Chair and CEO roles. WEX has reached a cooperation agreement with Impactive Capital that includes new board appointments and governance changes. The company has entered a partnership with Electric Era to expand fleet payment access to EV charging locations across the US. WEX, trading at $141.42, sits at the center of several material corporate decisions...

Schneider National (NYSE:SNDR) filed a shelf registration for an Employee Stock Ownership Plan related offering of approximately 19.9 million Class B shares. The filing covers up to US$610 million of securities that may be offered from time to time. The move centers on Class B common stock that is linked to employee ownership and incentive structures. Schneider National is a large North American trucking, intermodal, and logistics company, so any change in its equity structure tends to draw...

StoneCo (NasdaqGS:STNE) opened 2026 with Q1 revenue of R$3.6b and basic EPS of R$7.17, while trailing twelve month revenue stood at R$13.6b and EPS at R$14.00, framing a period where profitability has been firmly positive. Over the past year, the company has seen quarterly revenue move from R$3.2b in Q1 2025 to R$3.6b in Q1 2026, with basic EPS over those quarters ranging between R$1.83 and R$2.49 before stepping up to R$7.17 most recently. For investors, the key question now is how much of...

Pyxis Oncology (PYXS) has opened 2026 with Q1 results that keep the focus on scaling the top line while absorbing ongoing losses, with trailing 12 month revenue at about US$13.9 million and a basic EPS loss of roughly US$1.28 alongside net income losses of about US$79.6 million. Over recent quarters, the company has seen revenue move from US$0 in Q1 2025 to US$11.0 million in Q4 2025, while quarterly basic EPS losses have ranged between about US$0.29 and US$0.35 per share. For investors, that...

Many investors are considering whether Golar LNG is fairly priced at its current level, or whether the stock still offers value for new money going in. The stock last closed at US$57.04, with returns of 2.4% over the past week, 6.0% over the past month, 50.3% year to date and 47.9% over the past year. These moves may have influenced how investors view its potential and risk. Recent coverage has focused on Golar LNG's positioning within the energy sector and on how investors are reacting to...

AVITA Medical (NasdaqCM:RCEL) opened Q1 2026 with revenue of US$19.3 million and a basic EPS loss of US$0.35, while trailing twelve month figures show revenue of US$72.3 million and a basic EPS loss of US$1.57. The company has seen quarterly revenue move from US$18.5 million in Q1 2025 to US$19.3 million in Q1 2026, alongside quarterly EPS losses shifting from US$0.53 to US$0.35. This keeps the focus firmly on how quickly margins can tighten and losses can be contained. See our full analysis...

Boston Omaha (BOC) opened 2026 with Q1 revenue of about US$28.2 million and a basic EPS loss of US$0.07, alongside a trailing 12 month EPS loss of US$0.44 on revenue of roughly US$114.9 million. This keeps the stock in loss making territory at a share price of US$11.06. Over the past six quarters, revenue has moved in a tight band between roughly US$27.7 million and US$29.7 million per quarter, while quarterly basic EPS has ranged from a profit of US$0.17 to a loss of US$0.22. This points to...

Dillard's (DDS) has put up another solid quarter, with Q1 2027 revenue of US$1,588.6 million, basic EPS of US$16.06 and same store sales growth of 3%. Over the last few quarters, the company has seen revenue move from US$1,546.97 million in Q1 2026 to US$1,588.6 million in Q1 2027, while quarterly EPS has ranged from US$4.66 to US$16.06, giving investors a clear view of how sales and earnings are tracking together. Set against trailing 12 month EPS of US$42.10 and a net profit margin that has...

Alliance Entertainment Holding (AENT) has put up another busy quarter, with Q2 2026 revenue at US$368.7 million and basic EPS of US$0.18, feeding into trailing 12 month revenue of about US$1.1 billion and EPS of US$0.43 as the latest reference points ahead of the Q3 2026 update. Over the past year, the company has seen revenue range between US$227.8 million and US$393.7 million per quarter while quarterly EPS moved between roughly US$0.01 and US$0.18. This gives investors a clearer read on...

Vistance Networks (NasdaqGS:VISN) has filed a new shelf registration for a sizable common stock offering. The filing includes an employee stock ownership plan, or ESOP, related component tied to common shares. The move signals potential changes to the company’s capital structure and employee equity participation that investors may want to monitor. For readers tracking NasdaqGS:VISN, this filing lands after a period of sharp share price swings. The stock closed at $11.37, with the price up...

Earlier in May 2026, Rigel Pharmaceuticals announced an exclusive global licensing agreement with Arvinas and Pfizer for VEPPANU (vepdegestrant), an FDA‑approved oral PROTAC for certain advanced or metastatic ER+/HER2-, ESR1‑mutated breast cancers. This deal makes VEPPANU Rigel’s fourth commercial product and the first approved PROTAC in its portfolio, potentially reshaping the company’s oncology focus and product mix. We’ll now examine how adding VEPPANU as a globally licensed, FDA‑approved...

Abercrombie & Fitch (NYSE:ANF) has expanded its Your Personal Best (YPB) athleticwear line through a new partnership with NFL star TJ Watt. The company is launching an in store fan event featuring Watt, paired with a sweepstakes that brings shoppers into physical locations to engage with the YPB collection. For you as an investor watching NYSE:ANF, this move ties directly into how the company positions itself in casual and athletic apparel, a space where performance wear and lifestyle...

Karyopharm Therapeutics (KPTI) has opened Q1 2026 earnings season with revenue of about US$34.1 million in Q4 2025 and a basic EPS loss of US$5.71, providing a clear snapshot of a business still investing heavily for growth. Over recent quarters the company has seen revenue move between US$30.0 million and US$44.0 million, while basic EPS losses have ranged from roughly US$2.77 to US$5.71. This gives a tangible sense of how top line and per share results have been tracking into the latest...